Squamous Cell Carcinoma
253
30
45
106
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
54 trials with published results (21%)
Research Maturity
106 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
13.0%
33 terminated out of 253 trials
76.3%
-10.2% vs benchmark
4%
9 trials in Phase 3/4
51%
54 of 106 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 106 completed trials
Clinical Trials (253)
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Prospective Data Collection Initiative on Thoracic Malignancies
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Rigosertib for RDEB-SCC